期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Pattern of triptans use: a retrospective prescription study in Calabria, Italy
1
作者 Damiana Scuteri Annagrazia Adornetto +8 位作者 Laura Rombolà Maria Diana Naturale Adele Emanuela De Francesco Stefania Esposito Mariacristina Zito Luigi Antonio Morrone Giacinto Bagetta Paolo Tonin Maria Tiziana Corasaniti 《Neural Regeneration Research》 SCIE CAS CSCD 2020年第7期1340-1343,共4页
Triptans are 5-hydroxytryptamine 1 B/1 D receptor agonists used in moderate to severe migraine attacks as first line when non-specific,symptomatic,nonsteroidal anti-inflammatory drugs are not effective.To gain insight... Triptans are 5-hydroxytryptamine 1 B/1 D receptor agonists used in moderate to severe migraine attacks as first line when non-specific,symptomatic,nonsteroidal anti-inflammatory drugs are not effective.To gain insight in the treatment of migraine in the regional context,this retrospective(from January to August of the years 2017 and 2018)study aimed at monitoring the use of triptans approved by the regional health authority in Calabria.The data demonstrate that the overall treatment of migraine with triptans in the different provinces of Calabria falls in the average regional prescription/dispensation.Interestingly,Crotone showed a trend to an increased amount of defined daily dose/1000 inhabitants per day.The present analysis might stand for homogeneity of treatment of migraineurs in Calabria and highlights the need for better understanding the apparent differences in the local pattern of almotriptan use to improve the appropriateness. 展开更多
关键词 5-HT 1B/1D receptor agonists ALMOTRIPTAN CALABRIA DDD/1000 inhabitants per day MIGRAINE PHARMACOEPIDEMIOLOGY pharmacology of migraine prescriptions treatment triptans
下载PDF
FDA发布关于5-羟色胺受体激动剂Triptans用法的重要公众警告
2
《中华医学信息导报》 2006年第16期3-3,共1页
7月19日,FDA宣布一项关于将常用于治疗偏头痛的药物5-羟色胺受体激动剂(Triptans)与某些抗抑郁药同时使用的重要安全信息。将Triptans与选择性5-羟色胺再吸收抑制剂(SSRISs)或选择性5-羟色胺/去甲肾上腺素重吸收抑制剂(SNRIs)联... 7月19日,FDA宣布一项关于将常用于治疗偏头痛的药物5-羟色胺受体激动剂(Triptans)与某些抗抑郁药同时使用的重要安全信息。将Triptans与选择性5-羟色胺再吸收抑制剂(SSRISs)或选择性5-羟色胺/去甲肾上腺素重吸收抑制剂(SNRIs)联合应用可能会导致危及生命的血清素综合征。 展开更多
关键词 triptans 5-羟色胺 受体激动剂 重吸收抑制剂 公众 血清素综合征 去甲肾上腺素 SNRIs
原文传递
FDA发出曲坦类药物与SSRIs/SNRIs合用的警告
3
《中国处方药》 2006年第9期68-69,共2页
7月19日,FDA发出治疗偏头痛的药物5-羟色胺(5-HT)受体激动剂曲坦类药物(triptans)与一些抗抑郁药合用的安全信息警告。这些抗抑郁药是选择性5HT再摄取抑制剂(SSRIs)及选择性去甲肾上腺素重摄取抑制剂(SNRIS)。当triptans与SSRI... 7月19日,FDA发出治疗偏头痛的药物5-羟色胺(5-HT)受体激动剂曲坦类药物(triptans)与一些抗抑郁药合用的安全信息警告。这些抗抑郁药是选择性5HT再摄取抑制剂(SSRIs)及选择性去甲肾上腺素重摄取抑制剂(SNRIS)。当triptans与SSRIs或SNRIs合用时,可能发生致命性的5一羟色胺综合征。 展开更多
关键词 曲坦类药物 SNRIs SSRIS FDA 选择性去甲肾上腺素重摄取抑制剂 triptans 5-羟色胺 再摄取抑制剂 抗抑郁药 受体激动剂
下载PDF
Optimum Operating and Regeneration Parameters of ZnI2 Catalyst for Converting Methanol to Triptane:An Ideal Component of Unleaded Aviation Gasoline 被引量:3
4
作者 Chen Weiwei Song Yueqin +3 位作者 Zong Rui Du Changfei Zhou Xiaolong Li Chenglie 《China Petroleum Processing & Petrochemical Technology》 SCIE CAS 2018年第2期56-64,共9页
Conversion of methanol(MeOH) to 2,2,3-trimethylbutane(triptane) over zinc iodide(ZnI_2)catalyst was investigated in a closed batch reactor.Optimum operating parameters were searched and catalyst deactivation and regen... Conversion of methanol(MeOH) to 2,2,3-trimethylbutane(triptane) over zinc iodide(ZnI_2)catalyst was investigated in a closed batch reactor.Optimum operating parameters were searched and catalyst deactivation and regeneration behaviors were discussed.The fresh,spent and regenerated catalysts were characterized by XRD,TG and XRF measurements to elucidate the related mechanism.The experimental results showed that the triptane yield reached up to 12.2% under the process conditions,including a reaction temperature of 200℃,an initial pressure of 0.35 MPa,a reaction time of 2 h,and a Me OH to ZnI_2 molar ratio of 2.The catalyst was gradually deactivated after several run cycles.A small amount of iodine was lost and a certain amount of ZnO was formed on the deactivated ZnI_2 catalyst.Deactivation of the catalyst could be attributed to the reduction of ZnI_2 amount,resulted from iodine loss and formation of Zn O.It was firstly pointed out from our work that the deactivated catalyst could be well regenerated by the hydrogen iodide(HI) and the tert-butanol compensation method,wherein the latter was added as an initiator into the reaction system.The activity recovery of the deactivated(spent) catalyst might be related to the reformation of ZnI_2 and acceleration of the initiation step of this reaction. 展开更多
关键词 triptane zinc iodide METHANOL CATALYST REGENERATION DEACTIVATION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部